Literature DB >> 19954272

Inflammatory breast cancer: what are the treatment options?

Maria D Iniesta1, Colin J Mooney, Sofia D Merajver.   

Abstract

An otherwise healthy, 68-year-old woman presents to her primary-care physician complaining of right breast enlargement, warmth, and progressive pink to dark red skin changes over the past month. She denies fever, pain, or breast discharge. Physical examination reveals erythema of the whole right breast, warmth, swelling, induration, and nipple retraction. Palpable axillary lymphadenopathy is appreciated on the right only. The left breast is uninvolved. The physician is concerned that she may have inflammatory breast cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19954272     DOI: 10.1517/14656560903401638

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  2 in total

1.  Initial evaluation of inflammatory breast cancer with fluorodeoxyglucose positron emission tomography.

Authors:  Sait Sager; Sertac Asa; Rana Kaya Doner; Cem Leblebici; Metin Halac
Journal:  Indian J Nucl Med       Date:  2012-01

2.  Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.

Authors:  Bedrich L Eckhardt; Maria Gagliardi; LaKesla Iles; Kurt Evans; Cristina Ivan; Xiuping Liu; Chang-Gong Liu; Glauco Souza; Arvind Rao; Funda Meric-Bernstam; Naoto T Ueno; Geoffrey A Bartholomeusz
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.